MENU
CTSO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cytosorbents (CTSO) Earnings Date & Reports

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology... Show more

A.I. Advisor
published Earnings

CTSO is expected to report earnings to fall 30.60% to -3 cents per share on November 06

Cytosorbents CTSO Stock Earnings Reports
Q3'25
Est.
$-0.03
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.02
The last earnings report on August 07 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 98.41K shares outstanding, the current market capitalization sits at 62.61M.
View a ticker or compare two or three
CTSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CTSO showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of products to support healthcare professionals in the treatment of complex medical conditions

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
305 College Road East
Phone
+1 732 329-8885
Employees
186
Web
https://www.cytosorbents.com